The Commission proposes a new pharmaceutical strategy for Europe. It is a patient-centred strategy that aims to ensure the quality and safety of medicines, while boosting the sector’s global competitiveness. The EU needs to make sure that patients have access to high-quality, effective and safe medicines. It will foster patient access to innovative and affordable medicines. It will support the competitiveness and innovative capacity of the EU’s pharmaceutical industry.
Practical information
- Composition of the study group
- Administrator in charge / Assistant: Dalila BERNARD / Tanja STANOVNIK
- For more information please contact the INT Section Secretariat.